# Kimi K3 / mol-d02

Original final answer, shared by both scoring rounds.

# Proposed protocol: causal test of p53-dependent, damage-induced G1 arrest

**All experiments and analyses below are proposed; none are reported as completed.**

## Recommended design and conclusion criterion

Use one p53-competent parental clone to create a ligand-inducible, acute p53-depletion system and a matched degradation-resistant, near-endogenous wild-type p53 rescue. Run a blocked **3 p53-status × 2 damage × 2 caffeine factorial**, with the no-caffeine arms forming the primary confirmatory experiment.

For cells classified as G1 at damage, define arrest as:

1. survival through a calibrated observation horizon;
2. no mitosis;
3. no S-phase entry during live tracking; and
4. confirmation at the endpoint by 2N DNA content and absence of nucleotide incorporation.

Let \(A_{s,d}\) be the proportion of eligible G1 cells meeting this definition for p53 status \(s\) and damage condition \(d\). For intact \(I\), acutely depleted \(K\), and rescued \(R\) cells:

\[
\Delta_s=A_{s,\mathrm{damage}}-A_{s,\mathrm{vehicle}}
\]

The **primary quantitative contrast** is:

\[
C_{\mathrm{necessity}}=\Delta_I-\Delta_K
\]

A positive \(C_{\mathrm{necessity}}\) means acute p53 loss reduces damage-induced arrest. Rescue is then tested with:

\[
C_{\mathrm{rescue}}=\Delta_R-\Delta_K
\]

and full restoration is assessed by comparing \(\Delta_R\) with \(\Delta_I\). A claim that p53 is necessary and specifically restored is justified only if damage load is matched, depleted cells lose the response, near-endogenous rescue restores it, and the result is not explained by death, loss of non-G1 cells, or differential tracking.

---

## 1. Evidence-to-inference-to-conclusion chain

| Supplied evidence or limitation | Design inference | Required conclusion rule |
|---|---|---|
| The 1991 record associates p53 elevation with G1 arrest. | p53 abundance and cell-cycle state must both be measured under the selected damage condition. | Damage must first produce a reproducible live-cell G1-arrest phenotype in p53-intact cells. |
| Cells with missing or mutant p53 lacked the corresponding G1 response. | Acute loss in an otherwise unchanged background provides a stronger necessity test than comparing unrelated lines. | Acute depletion must reduce the damage-minus-vehicle arrest contrast. |
| Different cell lines cannot alone establish same-background causation. | All groups must derive from one parental clone, with matched passage, handling and reporter/vector background. | Genetic and batch controls must exclude degrader, tag or integration effects. |
| Reduced DNA synthesis may reflect death or altered population composition. | Cross-sectional 2N or incorporation-negative fractions are insufficient. Individual cells must be followed for survival, division and S-phase entry. | Death is scored as non-arrest in the primary analysis; survivor-only and fixed-population analyses are secondary. |
| Caffeine is pleiotropic. | Caffeine can test perturbation sensitivity but cannot independently prove a p53 mechanism. | Caffeine is a separate factorial perturbation and a secondary analysis, not part of the primary rescue claim. |

---

## 2. Biological system and preparation

### 2.1 Parental line qualification

1. Start from a single clonal parental population.
2. Document genotype, contamination status, growth rate and passage history.
3. In calibration experiments, expose the parent to the available damage agent and confirm:
   - measurable p53 abundance before and after damage;
   - a damage-dependent increase in live-cell G1 arrest;
   - an interpretable DNA-content distribution;
   - a death rate low enough to permit fate-resolved analysis.

If the parent does not show a damage-induced G1 response, it is not suitable for the proposed necessity test.

### 2.2 Acute p53-depletion system

Engineer all expressed endogenous p53 copies in the parental clone with a reversible, ligand-induced degradation tag.

Derive:

- **p53-intact line:** tagged p53, degradation-ligand vehicle.
- **Acute-depletion line:** same tagged line, degradation ligand.
- **Rescue line:** same tagged background plus a degradation-resistant wild-type p53 rescue allele.
- **Empty-rescue control:** same insertion/selection background without functional p53 rescue.
- **Ligand-specificity control:** untagged parental cells treated with degradation ligand.

Use at least two independently derived rescue clones to reduce the chance that an insertion site explains rescue. These remain derivatives of the same parental clone, not independent genetic backgrounds.

Prefer a rescue allele controlled by endogenous p53 regulatory elements at a defined locus. If that is technically impossible, use a minimally titrated promoter and describe the result as **near-endogenous abundance rescue**, not complete restoration of native regulation.

### 2.3 Live-cell phase classification

Because the hypothesis is specifically about G1, use a compatible live-cell cycle-phase reporter in all derivatives, or another validated live measure that identifies G1 at the time of damage.

If no phase-resolved live measurement is feasible, restrict analysis to cells born within a calibrated post-mitotic G1 interval before damage and confirm their endpoint state by correlative fixation. That substitute should be labeled less definitive because some tracked cells may enter S phase before damage.

---

## 3. Calibration experiments

Calibration data must be separate from confirmatory data. Do not select doses or time points after unblinding the main experiment.

### 3.1 p53 depletion calibration

Determine the shortest ligand exposure that:

- reduces endogenous tagged p53 below a prespecified fraction of the untreated tagged control or below the validated quantification limit;
- maintains depletion through the observation horizon;
- does not materially alter untreated-cell survival, cell-cycle transit or damage uptake.

Measure p53 at ligand addition, immediately before damage, shortly after damage and at the primary endpoint.

### 3.2 Rescue calibration

Titrate rescue expression and select the lowest condition that:

- produces total p53 abundance close to that of the p53-intact tagged line before damage;
- preserves a comparable damage-associated p53 abundance profile;
- does not alter baseline survival, division or cell-cycle distribution.

Set the near-endogenous equivalence margin before the main experiment using assay precision and an abundance-response calibration curve. If no expression level satisfies the margin, redesign rather than treating overexpression as rescue.

### 3.3 Damage-agent calibration

Keep the identity of the selected agent fixed. Vary exposure intensity or duration in p53-intact cells and select a condition that:

- produces a clear increase in live-cell G1 arrest;
- leaves enough surviving, trackable cells for analysis;
- does not produce such rapid death that arrest and death cannot be separated;
- yields a quantifiable initial damage load.

Calibrate the primary observation horizon \(T\) so that most untreated G1 cells have had sufficient opportunity to enter S phase or divide, while damaged p53-intact cells still show the arrest phenotype. Use an earlier secondary time point to check transient effects.

### 3.4 Matched damage load

Develop an agent-specific measurement of initial damage that is not merely a downstream p53 response—for example, direct lesion, adduct, uptake or another agent-specific physical measurement.

Use the same prepared exposure solution, exposure duration, temperature, medium, confluence and cell density. Measure damage load per cell immediately after exposure in every p53-status arm.

If initial damage-load distributions do not substantially overlap, the causal comparison is not valid. Correct the exposure procedure or restrict analysis to the overlapping load range. Do not compensate for a qualitatively different exposure by choosing a different nominal dose after seeing the arrest response.

### 3.5 Caffeine calibration

Calibrate caffeine separately from the p53 rescue experiment. Select the lowest caffeine exposure that reproducibly changes the damage-associated cell-cycle phenotype in p53-intact cells without excessive death. Include caffeine without damage to measure its independent effects.

Caffeine timing should be fixed after calibration and kept constant across p53 statuses.

### 3.6 DNA-content, incorporation and death calibration

- Optimize the nucleotide-analog pulse length so untreated S-phase cells are detectably labeled without prolonged incorporation.
- Establish analog-positive and analog-negative thresholds from no-analog and single-measurement controls.
- Establish 2N, S-phase and 4N boundaries from pooled untreated controls.
- Calibrate the death measurement using membrane integrity, morphology and, where available, a validated apoptosis/death marker.
- Verify that imaging illumination, analog pulse and death reagent do not themselves alter cell-cycle progression.

---

## 4. Confirmatory experimental units, allocation and blinding

### 4.1 Independent units

The primary experimental unit is an independently thawed, expanded and treated culture, not an individual cell or microscopy field. Cells within a culture are correlated observations.

Include both independent rescue clones in every experimental block. Determine the number of independent culture replicates by prospective power or precision simulation using pilot-estimated culture-to-culture variance and the smallest biologically meaningful change in \(C_{\mathrm{necessity}}\). Do not infer sample size from the historical record.

### 4.2 Blocking and randomization

Within each independent replicate block:

- include all main treatment combinations where feasible;
- randomize culture order, plate position, treatment order and imaging-field selection;
- balance passage number, cell density and operator;
- process all damage arms with a common exposure batch.

Genotype cannot be randomly assigned, but treatment, imaging and analysis order can be.

### 4.3 Blinding

Assign coded labels to cultures and image files. Staff performing live-cell annotation, fixed-measurement gating and primary analysis should not know status or treatment. Set gates and exclusion rules before decoding. Decode only after quality-control acceptance and analysis-code lock.

---

## 5. Main intervention and sampling order

### 5.1 Main factorial groups

Use three p53 statuses:

- \(I\): tagged p53, degradation-vehicle.
- \(K\): tagged p53, degradation ligand.
- \(R\): tagged p53 plus degradation-resistant rescue, degradation ligand.

Cross each status with:

1. damage vehicle + caffeine vehicle;
2. damage + caffeine vehicle;
3. damage vehicle + caffeine;
4. damage + caffeine.

The two caffeine-vehicle groups provide the primary p53 analysis; caffeine groups provide a separate perturbation analysis.

### 5.2 Additional specificity controls

Include, in smaller matched blocks:

- untagged parent ± degradation ligand ± damage;
- empty-rescue line ± degradation ligand ± damage;
- rescue line without degradation ligand ± damage.

These controls test ligand toxicity, insertion effects and rescue-expression effects but do not replace the primary comparison.

### 5.3 Ordered procedure

1. Plate all lines at the calibrated density in sister plates for live imaging and destructive endpoint assays.
2. Begin rescue expression at the calibrated time.
3. Add degradation ligand or vehicle at the calibrated time before damage.
4. Verify p53 depletion and rescue abundance in sister cultures immediately before damage.
5. Begin live imaging before damage to establish baseline and classify G1 cells.
6. At \(t=0\), apply damage or vehicle using a common, randomized exposure procedure.
7. Measure initial damage load immediately after exposure in dedicated cultures.
8. Add caffeine or vehicle at its calibrated time.
9. Continue live imaging through the calibrated horizon \(T\).
10. In parallel cultures, pulse with the nucleotide analog during prespecified windows.
11. Fix at early and primary endpoints for DNA content, nucleotide incorporation, p53 and damage-response measurements.
12. Measure death continuously where possible and again at endpoint in both tracked and sister cultures.

Do not change damage dose, caffeine dose, imaging horizon or gates between arms after outcomes are visible.

---

## 6. Measurements and prespecified gating

### 6.1 Live-cell tracking

For each eligible G1-at-\(t=0\) cell, record:

- survival or time and type of death;
- division time;
- S-phase-entry time, if reporter-based tracking is available;
- loss to tracking and reason.

The primary live-cell arrest event is survival to \(T\) without division or S-phase entry. Death is not arrest. Cells lost for technical reasons are censored, with sensitivity analyses for informative loss.

### 6.2 Fixed DNA content and nucleotide incorporation

At each fixed time point:

- gate intact single cells using prespecified morphology or scatter rules;
- retain a separate all-event analysis that includes dead or compromised events;
- classify 2N, S-phase and 4N DNA content using common gates;
- classify nucleotide incorporation using the no-analog threshold;
- report both proportions and absolute viable-cell counts.

An increased 2N fraction alone is not sufficient evidence of G1 arrest because preferential loss of S/G2 cells can produce the same distribution.

### 6.3 Death

Death is measured independently by:

- live-cell fate tracking;
- endpoint membrane integrity or a validated death marker;
- absolute recovery of viable cells.

Report death as a separate endpoint and score death before \(T\) as failure to arrest in the primary all-cohort analysis.

### 6.4 p53 and damage load

Measure p53 abundance in every independent replicate or in matched sister cultures at baseline, damage, early response and \(T\). Measure initial damage load per cell and, where useful, residual damage at later times. A p53-dependent downstream reporter must not be used as the sole measure of initial damage load.

---

## 7. Analysis plan

### 7.1 Primary estimand

For the caffeine-vehicle subset, estimate:

\[
\Delta_I,\quad \Delta_K,\quad \Delta_R
\]

using a model that treats independent cultures as the unit of replication—for example, a logistic mixed model or culture-level beta-binomial analysis. Include replicate block and rescue clone where applicable.

The primary test is:

\[
H_0:C_{\mathrm{necessity}}=0
\]

versus the two-sided alternative, with effect estimate and confidence interval. A positive result supports loss of arrest after acute p53 depletion.

### 7.2 Rescue analysis

If the primary necessity criterion is met, test:

\[
C_{\mathrm{rescue}}=\Delta_R-\Delta_K
\]

and:

\[
C_{\mathrm{full}}=\Delta_R-\Delta_I
\]

Interpret \(C_{\mathrm{rescue}}>0\) as restoration. Claim **full rescue** only if the rescue-minus-intact difference lies within a prespecified equivalence margin. Also report the rescue fraction:

\[
F=\frac{\Delta_R-\Delta_K}{\Delta_I-\Delta_K}
\]

when the denominator is clearly positive. \(F\approx0\) indicates no rescue, \(F\approx1\) full rescue, and values above one indicate overshoot.

### 7.3 Death and composition sensitivity analyses

Repeat the arrest analysis:

1. among survivors only;
2. with death modeled as a competing event;
3. excluding technically censored cells;
4. using fixed 2N/incorporation-negative fractions among all events and among viable cells.

If the live-cell result depends on how death or censoring is handled, report that fragility rather than selecting the favorable analysis.

### 7.4 Caffeine analysis

For each p53 status, estimate the caffeine effect on the damage response:

\[
B_s=A_{s,\mathrm{damage+caffeine}}-A_{s,\mathrm{damage}}
\]

Compare \(B_I\), \(B_K\) and \(B_R\), and include caffeine-alone contrasts. Treat these results as tests of caffeine sensitivity and interaction, not as independent proof of p53 mechanism.

### 7.5 Damage-load adjustment

If initial load is closely matched, report it as a quality-control variable. If modest imbalance occurs, use prespecified covariate adjustment or restriction to the overlapping load range. If overlap is inadequate, the causal p53 comparison is not admissible.

---

## 8. Acceptance and stopping criteria

Proceed to inference only if:

- tagged untreated cells behave equivalently to the untagged parent;
- ligand has no material effect in untagged cells;
- endogenous p53 depletion reaches the prespecified target and persists through \(T\);
- rescue abundance is within the prespecified near-endogenous margin;
- empty-rescue cells do not restore arrest;
- initial damage-load distributions overlap across statuses;
- tracking completeness and fixed-assay event counts meet the pilot-defined precision target;
- no-damage death and censoring remain below the pilot-defined limits;
- damage produces a detectable arrest response in p53-intact cells.

Stop and recalibrate if there is incomplete depletion, failed rescue, excessive death, nonoverlapping damage load, strong batch effects, or caffeine toxicity that obscures cell-cycle analysis.

---

## 9. Troubleshooting

- **Incomplete p53 loss:** adjust degradation-ligand timing or improve the degradation system; do not infer non-necessity from partial loss.
- **Rescue overexpression:** lower expression or use a different clone; overshoot should not be called physiological rescue.
- **Tagged-line baseline phenotype:** use an independent acute-depletion method or abandon the derivative.
- **No intact damage response:** recalibrate damage intensity and timing or select another parental clone.
- **Excessive death:** reduce damage exposure or shorten the horizon; otherwise arrest and death cannot be separated.
- **Unequal damage load:** standardize exposure and remeasure initial lesions; do not rescue nonoverlapping exposures solely by statistical adjustment.
- **Ambiguous nucleotide incorporation:** recalibrate pulse duration and thresholds with no-analog controls.
- **High tracking loss:** lower density, improve imaging or add fields; examine whether loss is treatment-dependent.
- **Clone-specific rescue:** require concordance across independent rescue clones; a single-clone result is vulnerable to insertion-site effects.

---

## 10. Interpretation, alternatives and limits

- **Loss and rescue both observed:** supports p53 as necessary for the tested damage-induced G1 arrest and indicates that the depletion phenotype is specifically reversible by near-endogenous p53 rescue.
- **No effect of depletion:** p53 is not necessary under those exact agent, dose, timing and culture conditions, not universally dispensable.
- **Loss without rescue:** may reflect off-target degradation effects, irreversible secondary changes or inadequate rescue; do not make a specific p53 claim.
- **Rescue overshoot:** suggests expression or regulation artifacts and supports only partial specificity.
- **Fixed 2N/low-incorporation shift without live-cell arrest:** indicates death or composition change rather than proven G1 arrest.
- **Caffeine suppression across statuses:** demonstrates caffeine-sensitive damage responses but, because caffeine is pleiotropic, does not establish the p53 mechanism.

The strongest conclusion remains conditional on the selected parental background and calibrated damage conditions. Acute p53 loss avoids chronic mutant-line adaptation, while matched damage load, fate-resolved tracking and rescue controls are what convert the historical association into a testable same-background causal claim.
